1 Antiemetic Drugs Market Overview
1.1 Product Overview and Scope of Antiemetic Drugs
1.2 Antiemetic Drugs Segment by Type
1.2.1 Global Antiemetic Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Dopamine Antagonist
1.2.3 5-HT-3 Receptor Antagonist
1.2.4 NK1 Receptor Antagonist
1.2.5 Cannabinoid Receptor Antagonist
1.3 Antiemetic Drugs Segment by Application
1.3.1 Global Antiemetic Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Chemotherapy
1.3.3 Gastroenteritis
1.3.4 Surgery
1.4 Global Antiemetic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antiemetic Drugs Revenue 2017-2028
1.4.2 Global Antiemetic Drugs Sales 2017-2028
1.4.3 Antiemetic Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antiemetic Drugs Market Competition by Manufacturers
2.1 Global Antiemetic Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antiemetic Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antiemetic Drugs Manufacturing Sites, Area Served, Product Type
2.5 Antiemetic Drugs Market Competitive Situation and Trends
2.5.1 Antiemetic Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antiemetic Drugs Players Market Share by Revenue
2.5.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiemetic Drugs Retrospective Market Scenario by Region
3.1 Global Antiemetic Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antiemetic Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antiemetic Drugs Market Facts & Figures by Country
3.3.1 North America Antiemetic Drugs Sales by Country
3.3.2 North America Antiemetic Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antiemetic Drugs Market Facts & Figures by Country
3.4.1 Europe Antiemetic Drugs Sales by Country
3.4.2 Europe Antiemetic Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antiemetic Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Antiemetic Drugs Sales by Region
3.5.2 Asia Pacific Antiemetic Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antiemetic Drugs Market Facts & Figures by Country
3.6.1 Latin America Antiemetic Drugs Sales by Country
3.6.2 Latin America Antiemetic Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Antiemetic Drugs Sales by Country
3.7.2 Middle East and Africa Antiemetic Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antiemetic Drugs Historic Market Analysis by Type
4.1 Global Antiemetic Drugs Sales Market Share by Type (2017-2022)
4.2 Global Antiemetic Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Antiemetic Drugs Price by Type (2017-2022)
5 Global Antiemetic Drugs Historic Market Analysis by Application
5.1 Global Antiemetic Drugs Sales Market Share by Application (2017-2022)
5.2 Global Antiemetic Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Antiemetic Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GlaxoSmithKline Antiemetic Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Johnson & Johnson Antiemetic Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Antiemetic Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Antiemetic Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Abbott Antiemetic Drugs Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bristol-Myers Squibb Antiemetic Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cipla Antiemetic Drugs Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Eisai
6.8.1 Eisai Corporation Information
6.8.2 Eisai Description and Business Overview
6.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Eisai Antiemetic Drugs Product Portfolio
6.8.5 Eisai Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eli Lilly Antiemetic Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Glenmark Antiemetic Drugs Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Helsinn Healthcare
6.11.1 Helsinn Healthcare Corporation Information
6.11.2 Helsinn Healthcare Antiemetic Drugs Description and Business Overview
6.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Helsinn Healthcare Antiemetic Drugs Product Portfolio
6.11.5 Helsinn Healthcare Recent Developments/Updates
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Corporation Information
6.12.2 Heron Therapeutics Antiemetic Drugs Description and Business Overview
6.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Heron Therapeutics Antiemetic Drugs Product Portfolio
6.12.5 Heron Therapeutics Recent Developments/Updates
6.13 IPCA Laboratories
6.13.1 IPCA Laboratories Corporation Information
6.13.2 IPCA Laboratories Antiemetic Drugs Description and Business Overview
6.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 IPCA Laboratories Antiemetic Drugs Product Portfolio
6.13.5 IPCA Laboratories Recent Developments/Updates
6.14 Lupin
6.14.1 Lupin Corporation Information
6.14.2 Lupin Antiemetic Drugs Description and Business Overview
6.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Lupin Antiemetic Drugs Product Portfolio
6.14.5 Lupin Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Antiemetic Drugs Description and Business Overview
6.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Merck Antiemetic Drugs Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Antiemetic Drugs Description and Business Overview
6.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Novartis Antiemetic Drugs Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 RedHill
6.17.1 RedHill Corporation Information
6.17.2 RedHill Antiemetic Drugs Description and Business Overview
6.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 RedHill Antiemetic Drugs Product Portfolio
6.17.5 RedHill Recent Developments/Updates
6.18 Sun Pharmaceutical Industries
6.18.1 Sun Pharmaceutical Industries Corporation Information
6.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio
6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.19 Takeda Pharmaceutical
6.19.1 Takeda Pharmaceutical Corporation Information
6.19.2 Takeda Pharmaceutical Antiemetic Drugs Description and Business Overview
6.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Takeda Pharmaceutical Antiemetic Drugs Product Portfolio
6.19.5 Takeda Pharmaceutical Recent Developments/Updates
7 Antiemetic Drugs Manufacturing Cost Analysis
7.1 Antiemetic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antiemetic Drugs
7.4 Antiemetic Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antiemetic Drugs Distributors List
8.3 Antiemetic Drugs Customers
9 Antiemetic Drugs Market Dynamics
9.1 Antiemetic Drugs Industry Trends
9.2 Antiemetic Drugs Market Drivers
9.3 Antiemetic Drugs Market Challenges
9.4 Antiemetic Drugs Market Restraints
10 Global Market Forecast
10.1 Antiemetic Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antiemetic Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Antiemetic Drugs by Type (2023-2028)
10.2 Antiemetic Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antiemetic Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antiemetic Drugs by Application (2023-2028)
10.3 Antiemetic Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antiemetic Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antiemetic Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
